Zur Entwicklung von Antitumor-Impfstoffen: ein synthetisches Konjugat aus tumorassoziiertem MUC1-Glycopeptidantigen und dem Tetanustoxin-Epitop
- 19 January 2001
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 113 (2) , 379-382
- https://doi.org/10.1002/1521-3757(20010119)113:2<379::aid-ange379>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Vom Labor zur Klinik: vollsynthetische Antitumor-Impfstoffe auf KohlenhydratbasisAngewandte Chemie, 2000
- From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer VaccinesAngewandte Chemie International Edition in English, 2000
- Glycosphingolipid antigens and cancer therapyChemistry & Biology, 1997
- Membrane-Bound (MUC1) and Secretory (MUC2, MUC3, and MUC4) Mucin Gene Expression in Human Lung CancerTumor Biology, 1996
- The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.Environmental Health Perspectives, 1990
- Synthetic tumor-associated glycopeptide antigens.Environmental Health Perspectives, 1990
- Synthesis of O‐Glycopeptides of the Tumor‐Associated TN‐ and T‐Antigen Type and Their Binding to Bovine Serum AlbuminAngewandte Chemie International Edition in English, 1986
- Synthese von O‐Glycopeptiden des tumorassoziierten TN‐ und T‐Antigen‐Typs und deren Anknüpfung an RinderserumalbuminAngewandte Chemie, 1986
- Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigensNature, 1985
- T and Tn, General Carcinoma AutoantigensScience, 1984